The Power of Visual Imagery in Drug Design. Isopavines as a New Class of Morphinomimetics and Their Human Opioid Receptor Binding Activity

Journal of Medicinal Chemistry
2003.0

Abstract

The importance of visual imagery and relational thinking manifests itself in a heuristic approach to the design and synthesis of potential morphinomimetics as agonists of the human mu receptor. The well-known class of alkaloids represented by the isopavine nucleus has a topological resemblance to the morphine skeleton, especially when viewed in a particular way. Enantiopure isopavines can be readily obtained from a 1,2 Stevens rearrangement of 13-substituted dihydromethanodibenzoazocines, prepared in four steps from d- and l-amino acids. Consideration of the topology and the expected orientation of the nitrogen lone pair for a better overlap with morphine necessitates the utilization of d-amino acids. By variation of the substituents on the aromatic rings and a judicious choice of ring substituents, it is possible to obtain low nanomolar binding to the human mu receptor while maintaining good to excellent mu/delta selectivity. Agonist-like activity is indicated in a functional assay for one of the analogues originally derived from d-alanine as a precursor. X-ray crystal structures of several compounds corroborate stereochemistries and overall topologies.

Knowledge Graph

Similar Paper

The Power of Visual Imagery in Drug Design. Isopavines as a New Class of Morphinomimetics and Their Human Opioid Receptor Binding Activity
Journal of Medicinal Chemistry 2003.0
Design, synthesis, pharmacological evaluation and molecular dynamics of β-amino acids morphan-derivatives as novel ligands for opioid receptors
European Journal of Medicinal Chemistry 2015.0
Morphiceptin Analogues Containing a Dipeptide Mimetic Structure:  An Investigation on the Bioactive Topology at the μ-Receptor
Journal of Medicinal Chemistry 2005.0
Pyridinomorphinans: Asymmetric synthesis of either enantiomer and opioid receptor binding selectivity
Tetrahedron Letters 1997.0
Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore models
Bioorganic & Medicinal Chemistry Letters 1998.0
Design, Synthesis, Pharmacological Evaluation, and Structure−Activity Study of Novel Endomorphin Analogues with Multiple Structural Modifications
Journal of Medicinal Chemistry 2011.0
Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan analogues as opioid receptor ligands
Bioorganic & Medicinal Chemistry 2015.0
N-methylnalorphine: definition of N-allyl conformation for antagonism at the opiate receptor
Journal of Medicinal Chemistry 1982.0
Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine’s Biological Activity
Journal of Medicinal Chemistry 2020.0
Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists
Journal of Medicinal Chemistry 2017.0